At the federal level, more than a dozen entities have begun to lobby on cannabis-related issues, including hemp and CBD, or adjusted their focus.
The amount of money that cannabis-focused entities spent on cannabis lobbying at the federal level fell for the third quarter in a row, following an unprecedented rise in 2019.
Trulieve is responsible for half of all cannabis product sales in Florida. According to state lobbying disclosures, the company is watching Florida’s neighbors, too.
One of the world’s largest cannabis companies is now lobbying in at least a half dozen states.
Cannabis Wire has found that major cannabis companies, like Canopy Growth, are registered to lobby.
Altria and Anheuser-Busch, previously lobbying on hemp and cannabis respectively, have now specified CBD as an area of interest.
After reaching new highs in 2019, lobbying by cannabis companies and groups continues to fall in 2020.
The company’s subsidiary donates big to attorneys general groups of both parties.
Compared to the last quarter, spending on cannabis-related issues is down somewhat, though some entities are pushing for coronavirus relief.
Two groups, including the campaign arm of The Heritage Foundation, joined an anti-cannabis veteran to oppose cannabis legislation in Congress.
Companies and organizations spent nearly $11 million on federal lobbying alone, vastly outpacing previous years. But given the coronavirus, 2020 is a mystery.
One of the largest and oldest CBD companies hopes to shape the state’s hemp industry, expected to be among the top in the nation.
Syngenta, which rejected an acquisition by Monsanto in 2015, is the latest major agriculture company monitoring the newly-legal market.
The supermarket giant started carrying CBD products last year. Now, it’s pressing the federal government on the issue.
Seven major schools have been working at the federal level toward access to cannabis for research and access to funding for research.
Some of the associations have pushed for the STATES Act, in addition to freedom to research and access to medical cannabis, Cannabis Wire has learned.